Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

Press Releases

Press Releases

  • Sep 05, 2019
    Wave Life Sciences Expands Board of Directors with Three New Appointments
    New independent directors bring deep expertise in drug development, commercial operations and government affairs CAMBRIDGE, Mass. , Sept. 05, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments
  • Aug 06, 2019
    Wave Life Sciences Appoints Mark Baldry as Chief Commercial Officer
    Commercial build-out to support anticipated launch of suvodirsen and other future commercialized products CAMBRIDGE, Mass. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for
  • May 22, 2019
    Wave Life Sciences to Present at the Jefferies 2019 Healthcare Conference
    CAMBRIDGE, Mass. , May 22, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno , MD, MBA, President and Chief Executive




  • Events and Presentation